See All Slides - tctmd.com

Slides

Presentation

Feasibility And Early Safety And Efficacy Outcomes Of Patients Undergoing Bioresorbable Vascular Scaffolds Implantation: The GHOST Registry – An Interim Report From The First 171 Patients Enrolled

Presenter: Corrado Tamburino

December 01, 2013

Presentation

The History of Innovation in Cardiovascular Care in Latin America

Presenter: Oscar A. Mendiz

December 01, 2013

Presentation

TAVI: Insight from Cardiac Anatomy

Presenter: Renu Virmani

December 01, 2013

Presentation

What We Don’t Know, But Need to Know About Renal Denervation

Presenter: Krishna Rocha-Singh

December 01, 2013

Presentation

Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent

Presenter: Martin T. Rothman

December 01, 2013

Presentation

Is Gender a Risk Factor? Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI): Results from the Real-World PARIS Reg

Presenter: Roxana Mehran

December 01, 2013

Presentation

Beyond Hypertension - “Off-target” Effects of Renal Denervation in Hypertensive Patients

Presenter: Eli Lev

December 01, 2013

Presentation

Should Mitral Valve be Tackled Percutaneously?

Presenter: Renu Virmani

December 01, 2013

Presentation

Combining Anticoagulant and Antiplatelet Treatment in Patients with Atrial Fibrillation Undergoing PCI - How to Minimize Bleeding and Ischemic Risks?

Presenter: Eli Lev

December 01, 2013

Presentation

Innovative Ideas from Clinical Practice in Pacing and Electrophysiology

Presenter: Minglong Chen

December 01, 2013

Advertisement

Slides

Feasibility And Early Safety And Efficacy Outcomes Of Patients Undergoing Bioresorbable Vascular Scaffolds Implantation: The GHOST Registry – An Interim Report From The First 171 Patients Enrolled

The History of Innovation in Cardiovascular Care in Latin America

TAVI: Insight from Cardiac Anatomy

What We Don’t Know, But Need to Know About Renal Denervation

Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent

Is Gender a Risk Factor? Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI): Results from the Real-World PARIS Reg

Beyond Hypertension - “Off-target” Effects of Renal Denervation in Hypertensive Patients

Should Mitral Valve be Tackled Percutaneously?

Combining Anticoagulant and Antiplatelet Treatment in Patients with Atrial Fibrillation Undergoing PCI - How to Minimize Bleeding and Ischemic Risks?

Innovative Ideas from Clinical Practice in Pacing and Electrophysiology

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content